SBIR/STTR Research Award

A Data-mining Approach to CAM Medication Reconciliation

Award identifier f86e2865bbcb78994bac57c9de0a93bca5d05a82cd11250d444da7494bdd0096Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$241,701

Program and phase

SBIR · Phase I

Award year

2012

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Transcendent International, LLC
Proposal award date
Not reported
Contract end date
Not reported
UEI
V5UPVWD193C7
Solicitation number
PA11-096
Topic code
NCATS

Research abstract

DESCRIPTION (provided by applicant): Due to its complex, multi-herb nature, many patients who use Complementary and Alternative Medicine (CAM) do not have full knowledge of the ingredients included in their remedies. Lack of disclosure about CAM can placepatients at risk, as some herbal products can have adverse interactions with pharmaceuticals or cause harmful side effects. This proposal seeks to address that challenge by developing a computer-aided expert system that can algorithmically determine the content of a patient's CAM herbal remedy. In the absence of reliable patient recall, the envisioned system employs proven analytics techniques and a known set of data- including historical patient records and patient-reported data, such as patient demographic and symptomatic details-to statistically generate a prescription list. The envisioned analytics engine will be a powerful clinical decision support tool that enhances patient safety and patient-provider communication surrounding CAM use. Phase I activities will generate a prototype for evaluating one frequently encountered condition: the common cold. This prototype will provide a solid foundation for system expansion, in Phase II, to cover a broad range of diseases and conditions. PUBLIC HEALTH RELEVANCE: Despite their growing prevalence, Complementary and Alternative Medicine (CAM) therapies are seldom a topic of discussion between healthcare professionals and patients; patient-provider communication and patient disclosure rates are further complicated by the language barrier (Eisenberg et al. 1993). Lack of communication about CAM can place patients at risk, as some herbal products can have adverse interactions with pharmaceuticals or cause harmful side effects (Kupiec et al. 2005). The computer-aided expert system, as envisioned in this application, will fill a critical void in our healthcare system's ability to thoroughly document CAM usage in patient medication history, equip providers to make more informed clinical decisions, and-by avoidance orearlier detection of herb-drug interactions-improve patient safety and quality of care.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

52 SBIR/STTR records share this UEI (2004–2025). Reported award amounts total $44,664,658. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.